iANTHUS CAPITAL HOLDINGS (ITHUF) Inventory Average (2021 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Inventory Average came in at $23.4 million in Q1 2026, up 12.02% year-on-year from $20.9 million in Q1 2025, and up 7.78% quarter-over-quarter from $21.7 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Inventory Average (2021 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Inventory Average across 6 years of filings, most recently posting $23.4 million for Q1 2026.
- Inventory Average for Q1 2026 came in at $23.4 million, up 12.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.4 million (up 12.02% YoY), and the FY2025 annual result was $22.4 million, down 6.54% from the prior year.
- Inventory Average came in at $23.4 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $21.7 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $32.3 million in Q2 2023 to a low of $20.5 million in Q2 2025.
- The 5-year median for Inventory Average is $25.1 million (2024), against an average of $26.2 million.
- Across the five-year window, Inventory Average rose 17.47% in 2022 and decreased 22.35% in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Inventory Average stood at $29.6 million in 2022, then dropped by 10.5% to $26.5 million in 2023, then declined by 13.0% to $23.0 million in 2024, then retreated by 5.73% to $21.7 million in 2025, then increased by 7.78% to $23.4 million in 2026.
- The last three Inventory Average figures came in at $23.4 million (Q1 2026), $21.7 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 180.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 131.60 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 66.75 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.73 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 266.66 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 79.60 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 63.01 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 23.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.40 Mn |
| Dec 31, 2025 | 21.71 Mn |
| Sep 30, 2025 | 21.48 Mn |
| Jun 30, 2025 | 20.55 Mn |
| Mar 31, 2025 | 20.89 Mn |
| Dec 31, 2024 | 23.03 Mn |
| Sep 30, 2024 | 24.49 Mn |
| Jun 30, 2024 | 25.08 Mn |
| Mar 31, 2024 | 25.07 Mn |
| Dec 31, 2023 | 26.48 Mn |
| Sep 30, 2023 | 30.20 Mn |
| Jun 30, 2023 | 32.29 Mn |
| Mar 31, 2023 | 30.78 Mn |
| Dec 31, 2022 | 29.58 Mn |
| Sep 30, 2022 | 29.25 Mn |
| Jun 30, 2022 | 30.54 Mn |
| Mar 31, 2022 | 30.32 Mn |
| Dec 31, 2021 | 29.34 Mn |
| Sep 30, 2021 | 28.82 Mn |
| Jun 30, 2021 | 26.92 Mn |